TraceLink expands offering with ROC IT Solutions acquisition
Company can now offer solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products.
TraceLink has acquired ROC IT Solutions, the leader in intelligent edge data capture for serialized product inventory in the pharmaceutical supply chain.
The acquisition positions TraceLink as the only end-to-end platform that enables life sciences companies to capture, process and exchange serialized product data across a digital supply chain network, while also more effectively managing warehouse product inventory at the “edge” of the supply chain.
By acquiring ROC IT and integrating EdgeTRAC into its family of serialization software, TraceLink now offers solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products. The acquisition also increases TraceLink’s physical presence in the US, bringing the total number of locations to two, including its global headquarters in North Reading, MA and a new office in Pittsford, NY.
“We are pleased to welcome ROC IT’s founding members, employees and valued customers to TraceLink. As industry pioneers and market leaders, both TraceLink and ROC IT have been working together since the early days of pharmaceutical track and trace, establishing an undeniable synergy with our respective technical expertise, industry knowledge and company cultures,” said Shabbir Dahod, president & CEO, TraceLink.
“This acquisition further widens our leadership position by seamlessly merging best-of-breed serialization capabilities into a comprehensive solution set that no other provider can offer. As a result, we’ll be able to serve broader serialization challenges in the pharmaceutical industry as well as explore new capabilities for real-time information sharing that support the longer-term business and patient safety goals of our customers.”
Larry Hall, co-founder and Vice President of Sales and Operations of ROC IT, added, “By joining forces with TraceLink, we have aligned ourselves with the winning team to build an even stronger collaboration to propel the industry forward. We look forward to this next chapter with TraceLink and ensuring the ongoing success of our customers, partners and team by leveraging TraceLink’s industry expertise, proven solutions and global customer success."
The specific warehouse operations capabilities now offered by TraceLink as a result of the ROC IT acquisition include
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance